Clinical Trial Update: Off-Label Use of Ribavirin in Management of Mucocutaneous Extrahepatic Manifestations of HCV Infection [NA]

View source ↗

Summary

This clinical trial update discusses the use of ribavirin off-label for mucocutaneous extrahepatic manifestations of hepatitis C, such as lichen planus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Diseases
• Hepatitis C
• Lichen Planus
• Vasculitis

Drugs mentioned

• Ribavirin (ribavirin)

Snippet

Sponsor: Tanta University | Conditions: Hepatitis C, Lichen Planus | NA | Status: UNKNOWN